EMO Biomedicine Corporation赞助的临床试验
总计14个结果
-
EMO Biomedicine CorporationFar Eastern Memorial Hospital完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation主动,不招人原发性骨髓纤维化 | 骨髓纤维化 | 真性红细胞增多症后澳大利亚, 奥地利, 比利时, 中国, 捷克语, 法国, 德国, 匈牙利, 意大利, 大韩民国, 荷兰, 波兰, 俄罗斯联邦, 西班牙, 爱尔兰, 英国
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的原发性骨髓纤维化 | 骨髓纤维化 | 真性红细胞增多症后骨髓纤维化 | 原发性血小板增多症后骨髓纤维化美国, 加拿大
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation可用的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation完全的
-
Denver Health and Hospital AuthorityMicrosoft Corporation; EMC Consulting完全的
-
Stichting European Myeloma NetworkCelgene Corporation; Healt Data Specialists - HeaDS (CRO); EMN Research Italy Impresa Sociale Srl主动,不招人
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); Population Health Research Institute; AMO Pharma; Hearts in Rhythm Organization (HiRO) 和其他合作者尚未招聘
-
Paris Translational Research Center for Organ TransplantationAgence de La Biomédecine; Eurotransplant; United Network for Organ Sharing; Deutsche Stiftung Organtransplantation 和其他合作者未知